CD19 and neoplasm: While short-term expression of CD19/CD20 CAR (5–7 days) may suffice to elicit significant cytotoxic effects of dual-target CAR-NK cells on tumor cells in vitro, its long-term efficacy in controlling tumor growth may be insufficient.